نتایج جستجو برای: dlbcl lymphoma

تعداد نتایج: 102737  

2016
Thibault Dupont ShaoNing Yang Jayeshkumar Patel Katerina Hatzi Alka Malik Wayne Tam Peter Martin John Leonard Ari Melnick Leandro Cerchietti

The BCL6 oncogene plays a crucial role in sustaining diffuse large B-cell lymphomas (DLBCL) through transcriptional repression of key checkpoint genes. BCL6-targeted therapy kills lymphoma cells by releasing these checkpoints. However BCL6 also directly represses several DLBCL oncogenes such as BCL2 and BCL-XL that promote lymphoma survival. Herein we show that DLBCL cells that survive BCL6-tar...

2016
Hilmar Quentmeier Hans G. Drexler Vivien Hauer Roderick A. F. MacLeod Claudia Pommerenke Cord C. Uphoff Margarete Zaborski Mattias Berglund Gunilla Enblad Rose-Marie Amini

Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma worldwide. We describe the establishment and molecular characteristics of the DLBCL cell line U-2946. This cell line was derived from a 52-year-old male with DLBCL. U-2946 cells carried the chromosomal translocation t(8;14) and strongly expressed MYC, but not the mature B-cell lymphoma associated oncogenes BCL...

2018
Chunyan Cheng Tao Wang Zhiqun Song Lijun Peng Mengqing Gao Olivier Hermine Sophie Rousseaux Saadi Khochbin Jian-Qing Mi Jin Wang

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma. R-CHOP is currently the standard therapy for DLBCL, but the prognosis of refractory or recurrent patients remains poor. In this study, we synthesized a new water-soluble antimalarial drug artemisinin derivative, SM1044. The treatment of DLBCL cell lines with SM1044 induces autophagy-dependent apoptosis, whi...

2017
Viola Puddinu Sabrina Casella Egle Radice Sylvia Thelen Stefan Dirnhofer Francesco Bertoni Marcus Thelen

Diffuse large B cell lymphoma (DLBCL) is the most frequent lymphoma accounting for more than the 30% of the cases. Involvement of extranodal sites, such as bone marrow and central nervous system, is associated with poor prognosis. A contribution of the chemokine system in these processes is assumed as it is known as a critical regulator of the metastatic process in cancer. The atypical chemokin...

2016
Jung Yong Hong Cheolwon Suh Won Seog Kim

Various strategies have been implemented to improve the outcomes of diffuse large B-cell lymphoma (DLBCL). In recent years, remarkable advances have been achieved, based on the discovery of cell-of-origin in DLBCL and on more effective targeted agents. This commentary will summarize recent updates on the evolution of frontline therapies for DLBCL, focusing on the upcoming promising frontline ch...

Journal: :Journal of BP Koirala Institute of Health Sciences 2022

Background: Immunophenotyping and improvement in classification system of lymphoma gains better epidemiological comparison incidence pattern. We aimed to study the spectrum clinic-epidemiological profile categorize type subtype according 2008 WHO system. Methods: This hospital-based retrospective, cross-sectional included all cases diagnosed a 5-year period from January 2012 December 2016. Demo...

Journal: :The Journal of Experimental Medicine 2003
Andreas Rosenwald George Wright Karen Leroy Xin Yu Philippe Gaulard Randy D. Gascoyne Wing C. Chan Tong Zhao Corinne Haioun Timothy C. Greiner Dennis D. Weisenburger James C. Lynch Julie Vose James O. Armitage Erlend B. Smeland Stein Kvaloy Harald Holte Jan Delabie Elias Campo Emili Montserrat Armando Lopez-Guillermo German Ott H. Konrad Muller-Hermelink Joseph M. Connors Rita Braziel Thomas M. Grogan Richard I. Fisher Thomas P. Miller Michael LeBlanc Michael Chiorazzi Hong Zhao Liming Yang John Powell Wyndham H. Wilson Elaine S. Jaffe Richard Simon Richard D. Klausner Louis M. Staudt

Using current diagnostic criteria, primary mediastinal B cell lymphoma (PMBL) cannot be distinguished from other types of diffuse large B cell lymphoma (DLBCL) reliably. We used gene expression profiling to develop a more precise molecular diagnosis of PMBL. PMBL patients were considerably younger than other DLBCL patients, and their lymphomas frequently involved other thoracic structures but n...

2016
Bianca Schuhmacher Benjamin Rengstl Claudia Döring Julia Bein Sebastian Newrzela Uta Brunnberg Hans Michael Kvasnicka Martine Vornanen Ralf Küppers Martin-Leo Hansmann Sylvia Hartmann

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is an indolent lymphoma, but can transform into diffuse large B cell lymphoma (DLBCL), showing a more aggressive clinical behavior. Little is known about these cases on the molecular level. Therefore, the aim of the present study was to characterize DLBCL transformed from NLPHL (LP-DLBCL) by gene expression profiling (GEP). GEP revealed an...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2012
Rajinder S Grover Kemp Kernstine Amrita Krishnan

PET scan and PET/CT scans are being widely used for staging of diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma. They are sensitive and specific imaging techniques available for lymphoma. However, practicing hematologists must be aware of false-positive tests, which can upgrade the stage of the lymphoma significantly and may alter the treatment paradigm for an individual patient. This...

Journal: :Scientific Data 2021

Abstract Diffuse Large B-Cell Lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. Though histologically DLBCL shows varying morphologies, no morphologic features have been consistently demonstrated to correlate with prognosis. We present a analysis of histology sections from 209 cases associated clinical and cytogenetic data. Duplicate tissue core were arranged in microarrays (TMAs), repl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید